🔎 Trials Near Me

Domov › Burkitov lymfóm › Nevada

Klinické štúdie Burkitov lymfóm v štáte Nevada

6 štúdií pre Burkitov lymfóm hľadá účastníkov v zariadeniach v štáte Nevada.

Mestá v štáte Nevada

Oficiálny text štúdie (anglicky)

A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)

  • Alliance for Childhood Diseases/Cure 4 the Kids Foundation, Las Vegas
Prebieha náborFáza 2
366 Days – 46 Years · Všetky pohlavia · Aktualizované 2. 10. 2026 · NCT06124157

Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia

  • OptumCare Cancer Care at Charleston, Las Vegas
  • OptumCare Cancer Care at Fort Apache, Las Vegas
Prebieha náborFáza 3
Vek 18 až 39 · Všetky pohlavia · Aktualizované 2. 10. 2026 · NCT03150693

Inotuzumab Ozogamicin and Blinatumomab With or Without Ponatinib in Treating Patients With Newly Diagnosed, Recurrent, or Refractory CD22-Positive B-Lineage Acute Lymphoblastic Leukemia

  • OptumCare Cancer Care at Charleston, Las Vegas
  • OptumCare Cancer Care at Fort Apache, Las Vegas
Prebieha náborFáza 2
Vek 18 a viac · Všetky pohlavia · Aktualizované 29. 9. 2026 · NCT03739814

Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia

  • Alliance for Childhood Diseases/Cure 4 the Kids Foundation, Las Vegas
Prebieha náborFáza 2
365 Days · Všetky pohlavia · Aktualizované 25. 9. 2026 · NCT06317662

A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)

  • Alliance for Childhood Diseases/Cure 4 the Kids Foundation, Las Vegas
  • Summerlin Hospital Medical Center, Las Vegas
  • Renown Regional Medical Center, Reno
Prebieha náborFáza 2
Vek 1 až 30 · Všetky pohlavia · Aktualizované 1. 9. 2026 · NCT04546399

Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy

  • Alliance for Childhood Diseases/Cure 4 the Kids Foundation, Las Vegas
  • Summerlin Hospital Medical Center, Las Vegas
  • Renown Regional Medical Center, Reno
Prebieha náborFáza 3
365 Days – 25 Years · Všetky pohlavia · Aktualizované 25. 8. 2026 · NCT03959085

Z ClinicalTrials.gov, dáta načítané 5. 10. 2026. Každá štúdia má vlastné kritériá oprávnenosti; tím štúdie rozhoduje o účasti.